RecruitingPhase 1DMT

The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)

Sponsored by Yale University

NCT ID
NCT06070649
Target Enrollment
63 participants
Start Date
2025-08-04
Est. Completion
2026-08-01

About This Study

This proposed study is a double-blind, randomized, placebo-controlled, parallel-group, laboratory study to determine the effects of DMT, plus psychotherapy, on Alcohol Use Disorder.

Conditions Studied

Alcohol Use Disorder (AUD)Alcohol-Related DisordersAlcohol Use

Interventions

  • 0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion
  • 0.2 mg/kg/min + Dimethyltryptamine 0.01mg/kg/min infusion
  • 25 mg Diphenhydramine (5 min) + Normal Saline

Eligibility

Age:21 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Diagnostic and Statistical Manual of Mental Disorders-5th edition (DSM-5) diagnosis of Alcohol Use Disorder
* Medically healthy
* Ability to provide consent

Exclusion Criteria:

* Unstable medical conditions

Study Locations (1)

Connecticut Mental Health Center
New Haven, Connecticut, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Ardavan Mohammad Aghaei
CONTACT
ardavan.mohammadaghaei@yale.edu
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD) | Huxley